Regeneron· @Regeneron · X·· 2026-04-13AI 评分22
AI 导读
我们正与Telix Pharmaceuticals合作，开发并商业化下一代放射性药物治疗，将我们领先的抗体发现/开发平台与Telix的放射性药物专长相结合。 阅读更多：https://bit.ly/4sqJSI1
正文
We are collaborating with Telix Pharmaceuticals to develop and commercialize next-generation radiopharmaceutical therapies, combining our leading discovery/development antibody platform with Telix’s radiopharmaceutical expertise.
Read more: https://bit.ly/4sqJSI1
来源：Regeneron · x.com